{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:30:15Z","timestamp":1794619815387,"version":"4.9.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"HS acknowledges the support of the UZ Leuven Klinische onderzoeks- en opleidingsraad (KOOR) and the Sofhea Leerstoel in de Stamceltransplantatie."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1038\/s41409-025-02521-5","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T18:03:46Z","timestamp":1738865026000},"page":"507-518","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Life 2.0: a comprehensive cross-sectional profiling of long-term allogeneic hematopoietic cell transplantation survivors compared to a matched general population cohort"],"prefix":"10.1038","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7568-8239","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Schoemans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Goris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Fieuws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Theunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristel","family":"Buv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbet","family":"Lammertijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greet","family":"Bries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"Demuynck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stef","family":"Meers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Schuermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Vrelust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadewijch","family":"De Samblanx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Griet","family":"Huysmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"Vergote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielle","family":"Beckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4257-5980","authenticated-orcid":false,"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"De Geest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Dobbels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"2521_CR1","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1200\/JCO.2010.33.7212","volume":"29","author":"JR Wingard","year":"2011","unstructured":"Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D, et al. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol: J Am Soc Clin Oncol. 2011;29:2230\u20139. https:\/\/doi.org\/10.1200\/JCO.2010.33.7212","journal-title":"J Clin Oncol: J Am Soc Clin Oncol"},{"key":"2521_CR2","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1200\/JCO.2009.25.6693","volume":"28","author":"PJ Martin","year":"2010","unstructured":"Martin PJ, Counts GW Jr., Appelbaum FR, Lee SJ, Sanders JE, Deeg HJ, et al. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol: J Am Soc Clin Oncol. 2010;28:1011\u20136. https:\/\/doi.org\/10.1200\/JCO.2009.25.6693","journal-title":"J Clin Oncol: J Am Soc Clin Oncol"},{"key":"2521_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbmt.2016.10.020","volume":"23","author":"M Battiwalla","year":"2017","unstructured":"Battiwalla M, Hashmi S, Majhail N, Pavletic S, Savani BN, Shelburne N. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: developing recommendations to improve survivorship and long-term outcomes. Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant. 2017;23:6\u20139. https:\/\/doi.org\/10.1016\/j.bbmt.2016.10.020.","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant"},{"key":"2521_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1200\/jco.2016.68.8457","volume":"35","author":"EJ Chow","year":"2017","unstructured":"Chow EJ, Cushing-Haugen KL, Cheng GS, Boeckh M, Khera N, Lee SJ, et al. Morbidity and mortality differences between hematopoietic cell transplantation survivors and other cancer survivors. J Clin Oncol: J Am Soc Clin Oncol. 2017;35:306\u201313. https:\/\/doi.org\/10.1200\/jco.2016.68.8457.","journal-title":"J Clin Oncol: J Am Soc Clin Oncol"},{"key":"2521_CR5","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3324\/haematol.2018.203919","volume":"104","author":"NS Majhail","year":"2019","unstructured":"Majhail NS, Murphy E, Laud P, Preussler JM, Denzen EM, Abetti B, et al. Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors. Haematologica. 2019;104:1084\u201392. https:\/\/doi.org\/10.3324\/haematol.2018.203919.","journal-title":"Haematologica"},{"key":"2521_CR6","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.bbmt.2018.03.023","volume":"24","author":"SK Hashmi","year":"2018","unstructured":"Hashmi SK, Lee SJ, Savani BN, Burns L, Wingard JR, Perales MA, et al. ASBMT practice guidelines committee survey on long-term follow-up clinics for hematopoietic cell transplant survivors. Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant. 2018;24:1119\u201324. https:\/\/doi.org\/10.1016\/j.bbmt.2018.03.023. e-pub ahead of print 2018\/04\/03","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant"},{"key":"2521_CR7","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.bbmt.2016.09.011","volume":"23","author":"M Bevans","year":"2017","unstructured":"Bevans M, El-Jawahri A, Tierney DK, Wiener L, Wood WA, Hoodin F, et al. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: the patient-centered outcomes working group report. Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant. 2017;23:538\u201351. https:\/\/doi.org\/10.1016\/j.bbmt.2016.09.011.","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant"},{"key":"2521_CR8","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1182\/blood-2009-06-229369","volume":"116","author":"CL Sun","year":"2010","unstructured":"Sun CL, Francisco L, Kawashima T, Leisenring W, Robison LL, Baker KS, et al. Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Blood. 2010;116:3129\u201339. https:\/\/doi.org\/10.1182\/blood-2009-06-229369.","journal-title":"Blood"},{"key":"2521_CR9","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1182\/blood-2007-03-082933","volume":"110","author":"S Bhatia","year":"2007","unstructured":"Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG, et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood. 2007;110:3784\u201392. https:\/\/doi.org\/10.1182\/blood-2007-03-082933.","journal-title":"Blood"},{"key":"2521_CR10","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1200\/jco.21.02829","volume":"40","author":"SH Armenian","year":"2022","unstructured":"Armenian SH, Chen Y, Hageman L, Wu J, Landier W, Bosworth A, et al. Burden of long-term morbidity borne by survivors of acute myeloid leukemia treated with blood or marrow transplantation: the results of the BMT survivor study. J Clin Oncol: J Am Soc Clin Oncol. 2022;40:3278\u201388. https:\/\/doi.org\/10.1200\/jco.21.02829.","journal-title":"J Clin Oncol: J Am Soc Clin Oncol"},{"key":"2521_CR11","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.1182\/blood-2011-04-348730","volume":"118","author":"CL Sun","year":"2011","unstructured":"Sun CL, Francisco L, Baker KS, Weisdorf DJ, Forman SJ, Bhatia S. Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS). Blood. 2011;118:4723\u201331. https:\/\/doi.org\/10.1182\/blood-2011-04-348730.","journal-title":"Blood"},{"key":"2521_CR12","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.bbmt.2013.04.002","volume":"19","author":"CL Sun","year":"2013","unstructured":"Sun CL, Kersey JH, Francisco L, Armenian SH, Baker KS, Weisdorf DJ, et al. Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study. Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant. 2013;19:1073\u201380. https:\/\/doi.org\/10.1016\/j.bbmt.2013.04.002.","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant"},{"key":"2521_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbmt.2016.10.011","volume":"23","author":"A Clavert","year":"2017","unstructured":"Clavert A, Peric Z, Brissot E, Malard F, Guillaume T, Delaunay J, et al. Late complications and quality of life after reduced-intensity conditioning allogeneic stem cell transplantation. Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant. 2017;23:140\u20136. https:\/\/doi.org\/10.1016\/j.bbmt.2016.10.011.","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant"},{"key":"2521_CR14","doi-asserted-by":"publisher","first-page":"6596","DOI":"10.1200\/jco.2005.12.674","volume":"23","author":"KL Syrjala","year":"2005","unstructured":"Syrjala KL, Langer SL, Abrams JR, Storer BE, Martin PJ. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol: J Am Soc Clin Oncol. 2005;23:6596\u2013606. https:\/\/doi.org\/10.1200\/jco.2005.12.674.","journal-title":"J Clin Oncol: J Am Soc Clin Oncol"},{"key":"2521_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1200\/jco.2011.38.4594","volume":"30","author":"N Khera","year":"2012","unstructured":"Khera N, Storer B, Flowers ME, Carpenter PA, Inamoto Y, Sandmaier BM, et al. Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation. J Clin Oncol: J Am Soc Clin Oncol. 2012;30:71\u201377. https:\/\/doi.org\/10.1200\/jco.2011.38.4594.","journal-title":"J Clin Oncol: J Am Soc Clin Oncol"},{"key":"2521_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11899-023-00694-8","volume":"18","author":"N Khera","year":"2023","unstructured":"Khera N. Managing survivorship after hematopoietic cell transplantation. Curr Hematologic Malignancy Rep. 2023;18:75\u201382. https:\/\/doi.org\/10.1007\/s11899-023-00694-8.","journal-title":"Curr Hematologic Malignancy Rep."},{"key":"2521_CR17","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/s41409-022-01715-5","volume":"57","author":"AS Del Galy","year":"2022","unstructured":"Del Galy AS, Rousseau A, Capes A, Michonneau D, Robin M, de Fontbrune FS, et al. Life expectancy and burden of late complications after reduced intensity conditioning allogeneic transplantation. Bone Marrow Transplant. 2022;57:1365\u201372. https:\/\/doi.org\/10.1038\/s41409-022-01715-5.","journal-title":"Bone Marrow Transplant"},{"key":"2521_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/bmt.2013.158","volume":"49","author":"HS Jim","year":"2014","unstructured":"Jim HS, Quinn GP, Gwede CK, Cases MG, Barata A, Cessna J, et al. Patient education in allogeneic hematopoietic cell transplant: what patients wish they had known about quality of life. Bone Marrow Transplant. 2014;49:299\u2013303. https:\/\/doi.org\/10.1038\/bmt.2013.158.","journal-title":"Bone Marrow Transplant"},{"key":"2521_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.687675","volume":"9","author":"M Parisek","year":"2021","unstructured":"Parisek M, Loss J, Holler E, Barata A, Weber D, Edinger M, et al. \u201cThis Graft-vs.-Host Disease Determines My Life. That\u2019s It.\u201d-a qualitative analysis of the experiences and needs of allogenic hematopoietic stem cells transplantation survivors in Germany. Front Public Health. 2021;9:687675. https:\/\/doi.org\/10.3389\/fpubh.2021.687675.","journal-title":"Front Public Health"},{"key":"2521_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/bmt.2012.5","volume":"47","author":"NS Majhail","year":"2012","unstructured":"Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant. 2012;47:337\u201341. https:\/\/doi.org\/10.1038\/bmt.2012.5.","journal-title":"Bone Marrow Transplant"},{"key":"2521_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1126\/science.847460","volume":"196","author":"G Engel","year":"1977","unstructured":"Engel G. The need for a new medical model: a challenge for biomedicine. Science. 1977;196:129\u201336. https:\/\/doi.org\/10.1126\/science.847460.","journal-title":"Science"},{"key":"2521_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/jama.1995.03520250075037","volume":"273","author":"IB Wilson","year":"1995","unstructured":"Wilson IB. Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. Jama. 1995;273:59\u201365.","journal-title":"Jama"},{"key":"2521_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1207\/S15324796ABM2601_01","volume":"26","author":"KR Lorig","year":"2003","unstructured":"Lorig KR, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26:1\u20137.","journal-title":"Ann Behav Med"},{"key":"2521_CR24","doi-asserted-by":"crossref","unstructured":"Schoemans H CHAPTER 44: Patient reported outcomes. In: Bipin N Savani AT (ed.) Blood and Marrow Transplantation Long Term Management: Survivorship after Transplant, 2021, pp 420\u20137.","DOI":"10.1002\/9781119612780.ch44"},{"key":"2521_CR25","unstructured":"Bergstralh E, Kosanke J Technical Report Series No. 56: Computerized matching to controls. Department of Health Sciences Research, Mayo Clinic: Rochester, Minn; 1995."},{"key":"2521_CR26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/10705500802222972","volume":"15","author":"BW Smith","year":"2008","unstructured":"Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief resilience scale: assessing the ability to bounce back. Int J Behav Med. 2008;15:194\u2013200. https:\/\/doi.org\/10.1080\/10705500802222972.","journal-title":"Int J Behav Med"},{"key":"2521_CR27","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1200\/JCO.2005.03.189","volume":"23","author":"MA Andrykowski","year":"2005","unstructured":"Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ, et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol: J Am Soc Clin Oncol. 2005;23:599\u2013608. https:\/\/doi.org\/10.1200\/JCO.2005.03.189.","journal-title":"J Clin Oncol: J Am Soc Clin Oncol"},{"key":"2521_CR28","doi-asserted-by":"publisher","first-page":"e0192761","DOI":"10.1371\/journal.pone.0192761","volume":"13","author":"A Chmitorz","year":"2018","unstructured":"Chmitorz A, Wenzel M, Stieglitz RD, Kunzler A, Bagusat C, Helmreich I, et al. Population-based validation of a German version of the Brief Resilience Scale. PloS one. 2018;13:e0192761. https:\/\/doi.org\/10.1371\/journal.pone.0192761.","journal-title":"PloS one"},{"key":"2521_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/sc.2016.75","volume":"55","author":"PJ Siddall","year":"2016","unstructured":"Siddall PJ, McIndoe L, Austin P, Wrigley PJ. The impact of pain on spiritual well-being in people with a spinal cord injury. Spinal Cord. 2016;55:105. https:\/\/doi.org\/10.1038\/sc.2016.75.","journal-title":"Spinal Cord"},{"key":"2521_CR30","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.3324\/haematol.2021.280413","volume":"107","author":"K Smeland","year":"2022","unstructured":"Smeland K, Holte H, Fagerli UM, Bersvendsen H, Hjermstad MJ, Loge JH, et al. Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life. Haematologica. 2022;107:2698\u2013707. https:\/\/doi.org\/10.3324\/haematol.2021.280413.","journal-title":"Haematologica"},{"key":"2521_CR31","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3324\/haematol.2010.030874","volume":"96","author":"A Rovo","year":"2011","unstructured":"Rovo A, Daikeler T, Halter J, Heim D, Tsakiris DA, Stern M, et al. Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor. Haematologica. 2011;96:150\u20135. https:\/\/doi.org\/10.3324\/haematol.2010.030874.","journal-title":"Haematologica"},{"key":"2521_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/bmt.2008.263","volume":"43","author":"NS Majhail","year":"2009","unstructured":"Majhail NS, Flowers ME, Ness KK, Jagasia M, Carpenter PA, Arora M, et al. High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2009;43:49\u201354. https:\/\/doi.org\/10.1038\/bmt.2008.263.","journal-title":"Bone Marrow Transplant"},{"key":"2521_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.bbmt.2016.08.019","volume":"23","author":"SH Armenian","year":"2017","unstructured":"Armenian SH, Chemaitilly W, Chen M, Chow EJ, Duncan CN, Jones LW, et al. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: the cardiovascular disease and associated risk factors working group report. Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant. 2017;23:201\u201310. https:\/\/doi.org\/10.1016\/j.bbmt.2016.08.019.","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant"},{"key":"2521_CR34","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2016.09.005","volume":"23","author":"LM Morton","year":"2017","unstructured":"Morton LM, Saber W, Baker KS, Barrett AJ, Bhatia S, Engels EA, et al. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: the subsequent neoplasms working group report. Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant. 2017;23:367\u201378. https:\/\/doi.org\/10.1016\/j.bbmt.2016.09.005.","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant"},{"key":"2521_CR35","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s00198-018-4669-4","volume":"29","author":"DL Kendler","year":"2018","unstructured":"Kendler DL, Body JJ, Brandi ML, Broady R, Cannata-Andia J, Cannata-Ortiz MJ, et al. Bone management in hematologic stem cell transplant recipients. Osteoporos Int: J Established Result Cooperation Eur Found Osteoporos Natl Osteoporos Found USA. 2018;29:2597\u2013610. https:\/\/doi.org\/10.1007\/s00198-018-4669-4.","journal-title":"Osteoporos Int: J Established Result Cooperation Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"2521_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/apa.13173","volume":"105","author":"K Tear Fahnehjelm","year":"2016","unstructured":"Tear Fahnehjelm K, Tornquist AL, Olsson M, Backstrom I, Andersson Gronlund M, Winiarski J. Cataract after allogeneic hematopoietic stem cell transplantation in childhood. Acta Paediatrica. 2016;105:82\u201389. https:\/\/doi.org\/10.1111\/apa.13173.","journal-title":"Acta Paediatrica"},{"key":"2521_CR37","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/bjh.13148","volume":"168","author":"M Horwitz","year":"2015","unstructured":"Horwitz M, Auquier P, Barlogis V, Contet A, Poiree M, Kanold J, et al. Incidence and risk factors for cataract after haematopoietic stem cell transplantation for childhood leukaemia: an LEA study. Br J Haematol. 2015;168:518\u201325. https:\/\/doi.org\/10.1111\/bjh.13148.","journal-title":"Br J Haematol"},{"key":"2521_CR38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bbmt.2009.09.011","volume":"16","author":"A Busca","year":"2010","unstructured":"Busca A, Falda M, Manzini P, D\u2019Antico S, Valfre A, Locatelli F, et al. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy. Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant. 2010;16:115\u201322. https:\/\/doi.org\/10.1016\/j.bbmt.2009.09.011.","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant"},{"key":"2521_CR39","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.bbmt.2010.01.004","volume":"16","author":"NS Majhail","year":"2010","unstructured":"Majhail NS, Lazarus HM, Burns LJ. A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors. Biol Blood Marrow Transplant. 2010;16:832\u20137. https:\/\/doi.org\/10.1016\/j.bbmt.2010.01.004.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2521_CR40","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.bbmt.2012.10.012","volume":"19","author":"SC Meyer","year":"2013","unstructured":"Meyer SC, O\u2019Meara A, Buser AS, Tichelli A, Passweg JR, Stern M. Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation. Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant. 2013;19:440\u20134. https:\/\/doi.org\/10.1016\/j.bbmt.2012.10.012.","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant"},{"key":"2521_CR41","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/cncr.10773","volume":"95","author":"L Tauchmanova","year":"2002","unstructured":"Tauchmanova L, Selleri C, Rosa GD, Pagano L, Orio F, Lombardi G, et al. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer. 2002;95:1076\u201384. https:\/\/doi.org\/10.1002\/cncr.10773.","journal-title":"Cancer"},{"key":"2521_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-8-143","volume":"8","author":"HH Konig","year":"2010","unstructured":"Konig HH, Heider D, Lehnert T, Riedel-Heller SG, Angermeyer MC, Matschinger H, et al. Health status of the advanced elderly in six European countries: results from a representative survey using EQ-5D and SF-12. Health Qual life outcomes. 2010;8:143. https:\/\/doi.org\/10.1186\/1477-7525-8-143.","journal-title":"Health Qual life outcomes"},{"key":"2521_CR43","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s11136-012-0322-4","volume":"22","author":"MF Janssen","year":"2013","unstructured":"Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22:1717\u201327. https:\/\/doi.org\/10.1007\/s11136-012-0322-4.","journal-title":"Qual Life Res"},{"key":"2521_CR44","doi-asserted-by":"publisher","unstructured":"Jiang C, Wang H, Wang Q, Luo Y, Sidlow R, Han X. Prevalence of chronic pain and high-impact chronic pain in cancer survivors in the United States. Lett JAMA Oncol. 2019. https:\/\/doi.org\/10.1001\/jamaoncol.2019.1439.","DOI":"10.1001\/jamaoncol.2019.1439"},{"key":"2521_CR45","doi-asserted-by":"publisher","first-page":"e12623","DOI":"10.1111\/ecc.12623","volume":"27","author":"VE Shanklin","year":"2018","unstructured":"Shanklin VE, Snowden JA, Greenfield DM. Late treatment effects following bone marrow transplant: efficacy of implementing international guidelines. Eur J cancer care. 2018;27:e12623. https:\/\/doi.org\/10.1111\/ecc.12623.","journal-title":"Eur J cancer care"},{"key":"2521_CR46","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s00520-010-0958-y","volume":"19","author":"CE Mosher","year":"2011","unstructured":"Mosher CE, DuHamel KN, Rini C, Corner G, Lam J, Redd WH. Quality of life concerns and depression among hematopoietic stem cell transplant survivors. Supportive Care Cancer: J Multinatl Assoc Supportive Care Cancer. 2011;19:1357\u201365. https:\/\/doi.org\/10.1007\/s00520-010-0958-y.","journal-title":"Supportive Care Cancer: J Multinatl Assoc Supportive Care Cancer"},{"key":"2521_CR47","first-page":"249","volume":"12","author":"U Gruber","year":"2003","unstructured":"Gruber U, Fegg M, Buchmann M, Kolb HJ, Hiddemann W. The long-term psychosocial effects of haematopoetic stem cell transplantation. Eur J Cancer Care. 2003;12:249\u201356.","journal-title":"Eur J Cancer Care"},{"key":"2521_CR48","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/bmt.2008.3","volume":"41","author":"P Niscola","year":"2008","unstructured":"Niscola P, Romani C, Scaramucci L, Dentamaro T, Cupelli L, Tendas A, et al. Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies. Bone Marrow Transplant. 2008;41:757\u201364. https:\/\/doi.org\/10.1038\/bmt.2008.3.","journal-title":"Bone Marrow Transplant"},{"key":"2521_CR49","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1182\/blood-2006-02-003954","volume":"108","author":"CJ Fraser","year":"2006","unstructured":"Fraser CJ, Bhatia S, Ness K, Carter A, Francisco L, Arora M, et al. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood. 2006;108:2867\u201373. https:\/\/doi.org\/10.1182\/blood-2006-02-003954.","journal-title":"Blood"},{"key":"2521_CR50","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41409-017-0055-7","volume":"53","author":"D Buchbinder","year":"2018","unstructured":"Buchbinder D, Kelly DL, Duarte RF, Auletta JJ, Bhatt N, Byrne M, et al. Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT. Bone Marrow Transplant. 2018;53:535\u201355. https:\/\/doi.org\/10.1038\/s41409-017-0055-7.","journal-title":"Bone Marrow Transplant"},{"key":"2521_CR51","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s41409-018-0138-0","volume":"53","author":"HSL Jim","year":"2018","unstructured":"Jim HSL, Sutton S, Majhail NS, Wood WA, Jacobsen PB, Wingard JR, et al. Severity, course, and predictors of sleep disruption following hematopoietic cell transplantation: a secondary data analysis from the BMT CTN 0902 trial. Bone Marrow Transplant. 2018;53:1038\u201343. https:\/\/doi.org\/10.1038\/s41409-018-0138-0.","journal-title":"Bone Marrow Transplant"},{"key":"2521_CR52","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.bbmt.2014.04.010","volume":"20","author":"HS Jim","year":"2014","unstructured":"Jim HS, Evans B, Jeong JM, Gonzalez BD, Johnston L, Nelson AM, et al. Sleep disruption in hematopoietic cell transplantation recipients: prevalence, severity, and clinical management. Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant. 2014;20:1465\u201384. https:\/\/doi.org\/10.1016\/j.bbmt.2014.04.010.","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant"},{"key":"2521_CR53","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41409-022-01869-2","volume":"58","author":"LK Gj\u00e6rde","year":"2023","unstructured":"Gj\u00e6rde LK, Eeltink C, Stringer J, Mooyaart J, Bosman P, Kenyon M, et al. Sexual function of adult long-term survivors and their partners after allogeneic hematopoietic cell transplantation in Europe (S-FAST): a study from the Transplant Complications Working Party and Nurses Group of the EBMT. Bone Marrow Transplant. 2023;58:195\u2013202. https:\/\/doi.org\/10.1038\/s41409-022-01869-2.","journal-title":"Bone Marrow Transplant"},{"key":"2521_CR54","doi-asserted-by":"crossref","unstructured":"Buysse A, Caen M, Dewaele A, Enzlin P, Lieven J, T\u2019Sjoen G, et al. Seksuele gezondheid in Vlaanderen, Academia Press: Gent; 2013.","DOI":"10.26530\/OAPEN_472415"},{"key":"2521_CR55","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/TP.0b013e3181ce77e5","volume":"89","author":"C De Baere","year":"2010","unstructured":"De Baere C, Delva D, Kloeck A, Remans K, Vanrenterghem Y, Verleden G, et al. Return to work and social participation: does type of organ transplantation matter? Transplantation. 2010;89:1009\u201315. https:\/\/doi.org\/10.1097\/TP.0b013e3181ce77e5.","journal-title":"Transplantation"},{"key":"2521_CR56","doi-asserted-by":"publisher","unstructured":"Persoon S, Buffart LM, Chinapaw MJM, Nollet F, Frings-Dresen MH, Koning S, et al. Return to work experiences of patients treated with stem cell transplantation for a hematologic malignancy. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. 2018. https:\/\/doi.org\/10.1007\/s00520-018-4596-0.","DOI":"10.1007\/s00520-018-4596-0"},{"key":"2521_CR57","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/bmt.2017.115","volume":"52","author":"A Tichelli","year":"2017","unstructured":"Tichelli A, Gerull S, Holbro A, Buser A, Nair G, Medinger M, et al. Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant. 2017;52:1436. https:\/\/doi.org\/10.1038\/bmt.2017.115.","journal-title":"Bone Marrow Transplant"},{"key":"2521_CR58","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/bmt.2014.26","volume":"49","author":"J Winterling","year":"2014","unstructured":"Winterling J, Johansson E, Wennman-Larsen A, Petersson LM, Ljungman P, Alexanderson K. Occupational status among adult survivors following allo-SCT. Bone Marrow Transplant. 2014;49:836. https:\/\/doi.org\/10.1038\/bmt.2014.26.","journal-title":"Bone Marrow Transplant"},{"key":"2521_CR59","doi-asserted-by":"publisher","unstructured":"OECD. Health at a Glance 2017: OECD Indicators. Paris: OECD Publishing; 2017. https:\/\/doi.org\/10.1787\/health_glance-2017-en.","DOI":"10.1787\/health_glance-2017-en"},{"key":"2521_CR60","doi-asserted-by":"publisher","unstructured":"Mohammed J, Smith SR, Burns L, Basak G, Aljurf M, Savani MB, et al. Role of physical therapy pre and post hematopoietic stem cell transplantation\u2014White paper report. Biology of blood and marrow transplantation: Journal of the American Society for Blood and Marrow Transplantation 2019. https:\/\/doi.org\/10.1016\/j.bbmt.2019.01.018.","DOI":"10.1016\/j.bbmt.2019.01.018"},{"key":"2521_CR61","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1016\/j.bbmt.2017.07.024","volume":"23","author":"T Hahn","year":"2017","unstructured":"Hahn T, Paplham P, Austin-Ketch T, Zhang Y, Grimmer J, Burns M, et al. Ascertainment of unmet needs and participation in health maintenance and screening of adult hematopoietic cell transplantation survivors followed in a formal survivorship program. Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant. 2017;23:1968\u201373. https:\/\/doi.org\/10.1016\/j.bbmt.2017.07.024.","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant"},{"key":"2521_CR62","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/bmt.2014.142","volume":"49","author":"M Kirsch","year":"2014","unstructured":"Kirsch M, Gotz A, Halter JP, Schanz U, Stussi G, Dobbels F, et al. Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study. Bone Marrow Transplant. 2014;49:1223\u201330. https:\/\/doi.org\/10.1038\/bmt.2014.142.","journal-title":"Bone Marrow Transplant"},{"key":"2521_CR63","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1182\/blood-2012-06-437178","volume":"120","author":"SH Armenian","year":"2012","unstructured":"Armenian SH, Sun CL, Vase T, Ness KK, Blum E, Francisco L, et al. Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease. Blood. 2012;120:4505\u201312. https:\/\/doi.org\/10.1182\/blood-2012-06-437178.","journal-title":"Blood"},{"key":"2521_CR64","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bbmt.2009.09.015","volume":"16","author":"MM Bishop","year":"2010","unstructured":"Bishop MM, Lee SJ, Beaumont JL, Andrykowski MA, Rizzo JD, Sobocinski KA, et al. The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls. Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant. 2010;16:207\u201314. https:\/\/doi.org\/10.1016\/j.bbmt.2009.09.015.","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transplant"},{"key":"2521_CR65","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41409-023-02190-2","volume":"59","author":"SJ Rotz","year":"2024","unstructured":"Rotz SJ, Bhatt NS, Hamilton BK, Duncan C, Aljurf M, Atsuta Y, et al. International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update. Bone Marrow Transplant. 2024;59:717\u201341. https:\/\/doi.org\/10.1038\/s41409-023-02190-2.","journal-title":"Bone Marrow Transplant"},{"key":"2521_CR66","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/bmt.2017.233","volume":"53","author":"J Lehrer","year":"2017","unstructured":"Lehrer J, Brissot E, Ruggeri A, Dulery R, Vekhoff A, Battipaglia G, et al. Medication adherence among allogeneic hematopoietic stem cell transplant recipients: a pilot single-center study. Bone Marrow Transplant. 2017;53:231. https:\/\/doi.org\/10.1038\/bmt.2017.233.","journal-title":"Bone Marrow Transplant"},{"key":"2521_CR67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/phar.2197","volume":"39","author":"J Zhou","year":"2019","unstructured":"Zhou J, Han J, Nutescu EA, Patel PR, Sweiss K, Calip GS. Discontinuation and nonadherence to medications for chronic conditions after hematopoietic cell transplantation: a 6-year propensity score-matched cohort study. Pharmacotherapy. 2019;39:55\u201366. https:\/\/doi.org\/10.1002\/phar.2197.","journal-title":"Pharmacotherapy"},{"key":"2521_CR68","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00520-012-1637-y","volume":"21","author":"J Sirilla","year":"2013","unstructured":"Sirilla J, Overcash J. Quality of life (QOL), supportive care, and spirituality in hematopoietic stem cell transplant (HSCT) patients. Supportive Care Cancer: J Multinatl Assoc Supportive Care Cancer. 2013;21:1137\u201344. https:\/\/doi.org\/10.1007\/s00520-012-1637-y.","journal-title":"Supportive Care Cancer: J Multinatl Assoc Supportive Care Cancer"},{"key":"2521_CR69","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/s00520-011-1310-x","volume":"20","author":"E Johansson","year":"2012","unstructured":"Johansson E, Larsen J, Schempp T, Jonsson L, Winterling J. Patients\u2019 goals related to health and function in the first 13 months after allogeneic stem cell transplantation. Supportive Care Cancer: J Multinatl Assoc Supportive Care Cancer. 2012;20:2025\u201332. https:\/\/doi.org\/10.1007\/s00520-011-1310-x.","journal-title":"Supportive Care Cancer: J Multinatl Assoc Supportive Care Cancer"},{"key":"2521_CR70","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1001\/jama.288.14.1775","volume":"288","author":"T Bodenheimer","year":"2002","unstructured":"Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. Jama. 2002;288:1775\u20139. https:\/\/doi.org\/10.1001\/jama.288.14.1775.","journal-title":"Jama"},{"key":"2521_CR71","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1182\/blood.V130.Suppl_1.745.745","volume":"130","author":"AD Sung","year":"2017","unstructured":"Sung AD, Nichols KR, Messina JA, Romero K, Dalton T, Bush A, et al. Hematopoietic stem cell transplantation at home. Blood. 2017;130:745\u2013745.","journal-title":"Blood"},{"key":"2521_CR72","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.bbmt.2018.05.004","volume":"24","author":"KL Syrjala","year":"2018","unstructured":"Syrjala KL, Crouch ML, Leisenring WM, Flowers MED, Artherholt SB, Fiscalini AS, et al. Engagement with INSPIRE, an Online Program for Hematopoietic Cell Transplantation Survivors. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2018;24:1692\u20138. https:\/\/doi.org\/10.1016\/j.bbmt.2018.05.004.","journal-title":"Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant"},{"key":"2521_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2020.101723","volume":"45","author":"L Leppla","year":"2020","unstructured":"Leppla L, Mielke J, Kunze M, Mauthner O, Teynor A, Valenta S, et al. Clinicians and patients perspectives on follow-up care and eHealth support after allogeneic hematopoietic stem cell transplantation: a mixed-methods contextual analysis as part of the SMILe study. Eur J Oncol Nurs : J Eur Oncol Nurs Soc. 2020;45:101723. https:\/\/doi.org\/10.1016\/j.ejon.2020.101723.","journal-title":"Eur J Oncol Nurs : J Eur Oncol Nurs Soc"},{"key":"2521_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/frhs.2022.977564","volume":"2","author":"S Valenta","year":"2022","unstructured":"Valenta S, Ribaut J, Leppla L, Mielke J, Teynor A, Koehly K, et al. Context-specific adaptation of an eHealth-facilitated, integrated care model and tailoring its implementation strategies-a mixed-methods study as a part of the SMILe implementation science project. Front Health Serv. 2022;2:977564. https:\/\/doi.org\/10.3389\/frhs.2022.977564.","journal-title":"Front Health Serv"},{"key":"2521_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2024.102740","volume":"74","author":"L Leppla","year":"2024","unstructured":"Leppla L, Kaier K, Schmid A, Valenta S, Ribaut J, Mielke J, et al. Evaluating the cost, cost-effectiveness and survival of an eHealth-facilitated integrated care model for allogeneic stem cell transplantation: results of the German SMILe randomized, controlled implementation science trial. Eur J Oncol Nurs: J Eur Oncol Nurs Soc. 2024;74:102740. https:\/\/doi.org\/10.1016\/j.ejon.2024.102740.","journal-title":"Eur J Oncol Nurs: J Eur Oncol Nurs Soc"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02521-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02521-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02521-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:25:23Z","timestamp":1743827123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02521-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["2521"],"URL":"https:\/\/doi.org\/10.1038\/s41409-025-02521-5","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HS reports having received personal fees from Incyte, Novartis, Sanofi, MAAT Pharma, Mallinckrodt Pharmaceuticals, and the Belgian Hematological Society (BHS), all paid to her institution and not directly related to this work. She has also received non-financial support from Pfizer, Sanofi, the EBMT (European Society for Blood and Marrow Transplantation), and the CIBMTR (Center for International Bone Marrow Transplantation Research). HS acknowledges the support of the UZ Leuven Klinische onderzoeks- en opleidingsraad (KOOR) of the University Hospitals of Leuven, Belgium. VV reports consultancy fees from Beigene, Cellgene, Gilead, Roche, Lilly Oncology, Johnsson & Johnsson, and Abbvie; travel support from Amgen, Abbvie, Gilead, Roche, all paid to her institution. The other authors have no relevant competing interests to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}